or
Remember me
Back
Calicalicali wrote: Would the FDA suggest a meeting to further discuss the path forward if there were to be a 'non-actionable' p3 trial though?
Receive investor kits and email updates from Stockhouse and directly from these companies.
At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!